Key Figures
Key figures from the annual report.
Key figures 2007
| Budget summary |
M. Ikr |
|---|---|
| Revenue |
404 |
| Expenditure |
427 |
| Staff |
290 |
| Balance |
-23 |
| Human Resources: |
|
|---|---|
| Staff |
Number |
| Total staff |
47 |
| Total fulltime posts |
39 |
| Staff turnover |
6,7% |
| Professions |
Number |
| MCP |
1 |
| Chemists |
2 |
| Dentist |
1 |
| Phycisians |
4 |
| Buisness administration |
2 |
| Pharmacy technicians |
7 |
| Pharmacists |
21 |
| Nurse |
1 |
| IT expert |
1 |
| Attorney at law - Advocate |
1 |
| Medicinal Chemists |
2 |
| Others |
4 |
| Gender |
Number |
| Female |
29 |
| Male |
18 |
| Average age |
46 years |
| Visit to website | |
|---|---|
| Home page |
313,513 |
| National Formulary |
209,131 |
| The Pharmaceutical Market |
|
|---|---|
| Industry |
Number |
| Industry |
10 |
| Wholesalers |
5 |
| Pharmacies, pharmacy branches, physicians' outlets |
97 |
| Others |
|
| Hospitals, Nursing homes and Health clinics |
174 |
| Veterinarians |
129 |
| Clinical Trials in progress |
58 |
| Average Pharmacy in Iceland |
Number |
| Opening hours per week |
52.9 |
| Prescriptions per year |
39,076 |
| Pharmacists |
1.4 |
| Pharmacy technician |
0.8 |
| Other employees |
2.5 |
| ATC | Cost and DDD |
M. Ikr* |
DDD/1000 inh./day |
|---|---|---|---|
| A | Alimentary tract and metabolism |
1,369 |
135,9 |
| B | Blood and blood forming organs |
801 |
130,2 |
| C | Cardiovascular system |
1,496 |
370,0 |
| D | Dermatologicals |
249 |
94 |
| G | Genito urinary system and sex hormones |
784 |
122,4 |
| H | System hormonal preparations excluding sex hormones |
269 |
31,6 |
| J | General antiinfectives, systemic |
1,115 |
23,1 |
| L | Antineoplastic and immunomoduling agents |
2,293 |
11,6 |
| M | Musculo-skeletal system |
586 |
83,7 |
| N | Central nervous system |
3,511 |
319,3 |
| P |
Antiparasitica |
25 |
1,2 |
| R | Respiratory system |
922 |
109,1 |
| S | Sensory organs |
244 |
10,5 |
| V | Various |
152 |
0,1 |
|
Total |
16,629 |
1,399 |
| Highest Turnover in Medicinal Products |
M. Ikr |
|---|---|
| Remicade inj. 100 mg |
292,1 |
| Nexium tabl. 20 mg 100 |
195,3 |
| Helixate NexGen inj. 100 iu |
194,9 |
| Ibufen tabl. 400 mg 30 |
180,4 |
| Nexium tabl. 40 mg 100 |
174,4 |
| Seretide Diskus inh 50+250 mcg 50 mcg/skx60 |
164,5 |
| Zarator tabl. 20 mg 98 |
137,6 |
| Cozaar Comp. tabl. 50 mg 98 |
130,0 |
| Enbrel (Lyfjaver) inj. 25 mg |
122,8 |
| Seretide Diskus inh 50+500 mcg 50 mcg/skx60 |
106,5 |
| Sandoglobulin inj. 12 g |
105,3 |
| Casodex tabl. 150 mg 30 |
100,9 |
| Rebif inj. 44 mcg |
100,2 |
| Herceptin inj. 150 mg |
99,6 |
| Paclitaxel Mayne inj 6 mg/ml 5 ml |
93,3 |
| Turnover |
M. Ikr* |
|---|---|
| Precription drugs |
9,973 |
| OTC-drugs |
2,195 |
| Hospitals and institutions |
4,461 |
| Total turnover |
16,629 |
|
Reference: The Ministry of Health and Social Security * Retail price incl. vat. Reference price list 12.2005 |
| Licencing Unit |
|
|---|---|
| Marketing authorisation and applications |
Number |
| Marketing authorisations |
3,426 |
| Applications in progress |
548 |
| New marketing authorisations |
243 |
| Renewals |
241 |
| Withdrawals |
149 |
| Inspection Unit |
|
|---|---|
| Overview |
Number |
| Inspections |
17 |
| Inspected Medicinal Products on the market |
10 |
| Certificates issued |
663 |
| Classification of products |
47 |
| Rapid Alerts |
71 |
| Circulars |
2 |
|
Inspections |
|
| Industry |
4 |
| Pharmacies and pharmacy branches |
4 |
| Wholesalers |
2 |
| Inspection not scheduled |
5 |
| GMP – inspections |
2 |
| Total |
17 |
| Advers reactions |
Number of reports |
|
Human Medicinal Products |
71 |
|
Veterinary Medicinal Products |
1 |
|
Clinical trials |
Number |
|
Commercial |
19 |
|
Non commercial |
6 |
